Search

Your search keyword '"Vancheri, Carlo"' showing total 867 results

Search Constraints

Start Over You searched for: Author "Vancheri, Carlo" Remove constraint Author: "Vancheri, Carlo"
867 results on '"Vancheri, Carlo"'

Search Results

2. Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers

4. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

5. Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World.

6. A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis

8. Developing PI3K Inhibitors for Respiratory Diseases

11. Quantum-inspired Minimum Distance Classification in Biomedical Context

12. The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study

13. Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study

14. A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)

17. Eosinophilic Bronchiectasis: Prevalence, Severity, and Associated Features—A Cohort Study.

18. Highlights on Future Treatments of IPF: Clues and Pitfalls.

19. Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis. An International Modified Delphi Survey

20. Melatonin Enhances Neural Differentiation of Adipose-Derived Mesenchymal Stem Cells

21. Distance follow-up by a remote medical care centre improves adherence to CPAP in patients with obstructive sleep apnoea over the short and long term

22. Diagnostic delay in bronchiectasis: an Italian perspective

27. Prevalence of Progressive Fibrosing Interstitial Lung Disease in Patients with Primary Sjogren Syndrome.

30. A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis

31. The Pattern and Progression of “Usual” Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis

32. Histogram-based analysis in progressive pulmonary fibrosis: relationships between pulmonary functional tests and HRCT indexes

34. Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?

40. Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial

43. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

45. An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies

46. Predictors of Stability/Improvement of Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis After One Year of Treatment With Nintedanib

48. Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?

Catalog

Books, media, physical & digital resources